Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension of the Phase III Study CL-758007 With Tramiprosate (3APS) in Patients With Alzheimer's Disease

NCT00314912 is registered in ClinicalTrials.gov with Bellus Health Inc. - a GSK company as lead sponsor.

NCT NCT00314912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension of the Phase III Study CL-758007 With Tramiprosate (3APS) in Patients With Alzheimer's Disease
Lead sponsor
Bellus Health Inc. - a GSK company
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2006
Completion date
Not reported
Enrollment
650
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease